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Tinospora crispa Beumee, a herbaceous climber, has been widely used in traditional medicine for 
treating various ailments such as contusion, septicaemia, fever, fracture, scabies and other tropical 
ulcers. A wide range of secondary metabolites such as alkaloids, diterpenes, flavones, phenolics, and 
triterpenes have been isolated, some of which have also shown corresponding biological activities. The 
current review is an update on the reported pharmacological activities and phytochemical constituents 
of T. crispa. 
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Tinospora crispa Beumee (Menispermaceae) 
[syn: T. tuberculata] or known as “akar patawali” 
or “akar seruntum” in Malaysia and “Borapet” in 
Thai and “Da ye ruan jin teng” in Chinese, is a 
herbaceous climbing plant that is widely 
distributed in South East Asia, particularly in 
Vietnam, Thailand, Malaysia, Indonesia and India 
[1-5].  This medicinal herb has been used in the 
Thai traditional medicine due to its anti-pyretic, 
antidiabetic, anti-inflammatory, anti-malarial and 
health maintaining properties [6]. It is also has 
been used in Chinese traditional medicine for the 
treatment of contusion, septicaemia, fever, 
fracture, scabies and other tropical ulcer related 
disorders [5,7]. Oral administration of the 
decoction of the stem of the plant is claimed to 
possess anti-malarial and anti anthelmintic 
properties whereas decoction of the whole plant 
has been used as a postpartum remedy and also 
a traditional remedy for diabetes among the 
Malay community [3,8-12]. A poultice of fresh 
leaves is reported for treatment of wounds and 
itches [1,13].  
 
PREVIOUS ISOLATION AND CHEMICAL 
INVESTIGATION 
 
Phytochemical investigation of the stems of T. 
crispa has led to the isolation of N-trans-feruloyl 
tyramine and N-cis-feruloyl tyramine from the 
ethyl acetate fraction as well as a phenolic 
glucoside, namely, tinotuberide (1) from the 
butanol fraction [14]. In 1985, a diterpene 
glucoside, borapetoside A (2), and its aglycone, 
borapetol A (3) were isolated from the stems of 
T. crispa, followed by the isolation of 
borapetoside B (4), and its aglycone, borapetol B 
(5) on the subsequent year [15-16]. The 
presence of borapetoside C–H (6-11) and 
tinotufolin A–F (12-17) were identified from the 
stems of the plant [17-20].  
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(2) R1 = -O-β-D-glc.pyr., R2 = R3 = H 
(3) R1 = OH, R2 = R3 = H 
 
(4) R1 = H, R2 = OH, R3 = -O-β-D-glc.pyr. 
(5) R1 = H, R2 = R3 = OH 
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Figure 3: Compounds 11 - 17 
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Umi Kalsom & Noor [21] reported from the stems 
of T. crispa five flavone glycosides which were 
identified as luteolin 4’-methyl ether 7-glucoside, 
genkwanin 7-glucoside, luteolin 4’-methyl ether 
3’-glucoside, diosmetin and genkwanin. 
 
Lin [22] isolated twelve constituents from the 
methanol extract of the stems of T. crispa, which 
included β-sitosterol, stigmasterol, apigenin, N-
formylanonaine, N-formylnornuciferine, 
cycloeucalenol, N-cis-feruloyltyramine, N-trans-
feruloyltyramine, whereas this was the first report 
of makisteron C, N-acetylanonaine, N-
acetylnornuciferine, N-trans-caffeoyltyramine 
from T. crispa.    
 
The phytochemical investigations of the stems of 
T. crispa afforded one new aporphine alkaloid, N-
formylasimilobine 2-O-β-D-glucopyranoside (18) 
(Figure 4), along with N-formylasimilobine 2-O-β-
D-glucopyranosyl-(1 → 2)-β-D-glucopyranoside 




feruloyltyramine and cytidine [23].  
 
 
Figure 4: Compound 18 
 
Choudhary et al. [24] also isolated nine new cis-




olid-18-oic acid methyl ester (19) (Figure 5 and 
6), (2R,5R,6R,8R,9S,10S,12S)-15,16-epoxy-2-
hydroxy-6-O-(β-D-glucopyranosyl)-cleroda- 
3,13(16),14-trien-17,12-olid-18-oic acid methyl 
ester (20), (5R,6R,8S,9R,10R,12S)-15,16-epoxy-
2-oxo-6-O-(β-D-glucopyranosyl)-cleroda-
3,13(16),14-trien-17,12-olid-18-oic acid methyl 










methyl ester (24), (5R,6S,9S,10S,12S)-15,16-
epoxy-2-oxo-6-O-(β-D-glucopyranosyl)-cleroda-
3,7,13(16),14-tetraen-17,12-olid-18-oic acid 
methyl ester (25),  
(3R,4R,5R,6S,8R,9S,10S,12S)-15,16-epoxy-3,4-
epoxy-6-O-(β-D-glucopyranosyl)-cleroda-
3,13(16),14-trien-17,12-olid-18-oic acid methyl 




   
(19) R1 = H, R2 = OH, 
R3= β-{β-D-
glucopyranosyl-(1-6)-α-
D-xylopyranose}, R4 = α-
H 
(20) R1 = H, R2 = OH, 
R3= β-(β-D-
glucopyranosyl), R4 = β-
H 
(21) R1 = R2 = C=O, R3= 
β-(β-D-glucopyranosyl), 






















Figure 6: Compounds 26 and 27 
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Chung [25] revealed the presence of forty 
phytochemical constituents, namely, borape-
toside A, borapetoside B, borapetoside C, 
borapetoside D, borapetoside E, borapetoside F, 
(2R,5R,6R,8R,9S,10S,12S)-15,16-epoxy-2-
hydroxy-6-O-(β-D-glucopyranosyl)-cleroda-







poside A, tinocrisposide B, tinocrisposide C, 
tinocrisposide D, rumphioside A, rumphioside B, 
rumphioside C, rumphioside F, rumphioside I, 
borapetol A, borapetol B, borapetic acid A, 






caffeoyltyramine, paprazine, trans-isoferulic acid, 
acantrifoside E, 3-hydroy-3-methylglutaryl-
acantrifoside E, apigenin, secoisolariciresinol, 
syringaresinol and cycloeucalenol from the 
methanol extract of T. crispa. 
 
PHYTOCHEMICAL INVESTIGATIONS BASED 
ON BIO‐ACTIVITY 
 
Cavin et al [26] examined the dichloromethane 
extract of T. crispa and indicated the presence of 
vanillin, syringin, N-formylannonain, N-
formylnornuciferin, borapetosides B, C and F, N-
cis-feruloyltyramine, N-trans-feruloyltyramine and 
secoisolariciresinol. Antioxidant and free-radical 
scavenging activity of N-cis-feruloyltyramine, N-
trans-feruloyltyramine and secoisolariciresinol 
were found to exhibit higher antioxidative 
potency than the synthetic antioxidant 
butylhydroxytoluene (BHT).  
  
The presence of two triterpenes, namely, 
cycloeucalenol and cycloeucalenone were 
reported for the first time from the chloroform 
extracts of the dried stems of T. crispa. Both of 
the isolated triterpenes further indicated mild 
cardiotonic effects, where cycloeucalenol 
showed slight increased in the right atrial 
contraction and initial reduction followed by 10 % 
of sustained reduction on the left atria of the rat 
in vitro meanwhile cycloeucalenone, showed 
slight change on the right and left atrial 
contraction [27]. 
 
Imphanban et al [28] isolated an aporphine 
alkaloid, namely, (-)-N-formylnornuciferine from 
the stems of T. crispa, which revealed in vitro 
cardiotonic activity. Synthesis of the mixture, (±)-
N-formylnornuciferine, via palladium-catalyzed 
coupling reaction, indicated significant reduction 
in the force of contraction and the heart rate.   
 
Bioassay guided fractionation of the n-butanol 
extract of the stems of T. crispa has resulted the 
isolation of five pharmacologically active 
compounds which were identified as salsolinol, 
adenosine, uridine, tyramine and higenamine, 
along with seven non-active compounds, namely, 
syringing, borapetoside A, B, D and E, adenine 
and litcubinine. The investigation of the 
pharmacologically active compounds on 
mechanisms of action on the blood pressure and 
heart rate in anesthetized, normal and 
reserpinized rats in vivo were carried out. The 
results of investigation further suggested that the 
cardiovascular responses of the anesthetized 
rats towards salsolinol, tyramine and higenamine 
were acted through the stimulation of the 
adrenoreceptors, whereby uridine and adenosine 
acted via the purinergic adenosine A2 and P2 
receptors to decrease blood pressure with a 
transient decrease of heart rate followed by an 
increase [29].   
 
Lam et al [30] isolated three new diterpenoids, 
namely, 2-O-lactoylborapetoside B (28) (Figure 
7), 6’-O-lactoylborapetoside B (29) and 
tinocrispol A (30), along with nine known 
diterpenoids, identified as borapetosides A-F, 
borapetols A and B and columbin from the 
ethanolic extract of T. crispa vines. 
Borapetosides A and C were found to lower the 
plasma glucose levels in normal and 
streptozotocin-induced type 1 diabetic mice upon 















(28) R1 = O-lactoyl, R2 = H
(29) R1 = OH, R2 = lactoyl
MeO O
 
Koay & Amir 





Figure 7: Compounds 28 – 30 
 
BIOLOGICAL ACTIVITIES AND 




The antibacterial studies conducted by Al-alusi et 
al. [31] has shown a promising antibacterial 
activity of T. crispa extracts against the 
Methicillin-resistant Staphylococcus aureus 




The aqueous extract of dried stems of T. crispa, 
assessed for in vitro antifilarial effects, has 
indicated moderate activity against the adult 
worms of subperiodic Brugia malayi after the 
aqueous extract of Xylocarpus granatum and 
dried leaves of Andrographis paniculata, 
whereby the value of relative movability values 
were used as a measure of the antifilarial activity 
[32]. The aqueous extract of T. crispa was found 
to exhibit microfilaricidal activity which the 
microfilaricidal activity was investigated based 





The study of Noor and Ashcroft [34] indicated 
that the orally administrated extract of T. crispa 
exhibited significant antihyperglycaemic effect. 
The extract may consist of compounds which 
initiated the insulin secretion through the 
modulation of β-cell Ca2+ concentration. Thus, it 
can be further used as an antidiabetic agent for 
the treatment of type II diabetes.  
 
Anti-nitric oxide (Anti-NO) activity 
 
The aqueous extract of T. crispa was found to 
suppress nitric oxide oxide production by 
lipopolysaccharide-stimulated murine 
macrophages. Significant inhibitory activity 
against the NO level and inducible NO synthase 
was showed by ethyl acetate layer when 
partitioned with the aqueous extract. Both 
subfraction of E-3 and N-trans-feruloyltyramine 




Based on DPPH, FRAP and TBA tests, the 
aqueous crude extract of T. crispa stem was 
found to exhibit high antioxidant activity and its 
antioxidative potency is comparable to the 
established antioxidants, such as BHT and 
vitamin C [37,38]. The antioxidant activity carried 
by Froemming [39] indicated that the methanol 
extract of T. crispa showed the highest 
antioxidant activity which was determined by 
measuring total flavonoid content, total phenolic 
content and DPPH free radical scavenging 




Rungruang & Boonmars [40] studied the in vivo 
antimalarial effect of the crude extract of    
T. crispa and the mice administrated of the 
extract with a dose of 80 mg/kg once a day were 
found to exhibit promising inhibitory activity 




The result of anti-proliferative activity of the 
aqueous crude extract of T. crispa stem indicated 
a significant cytotoxic effect on certain human 
cancer cell lines such as MCF-7 (IC50: 107 
μg/mL), HeLa (IC50: 165 μg/mL), Caov-3 (IC50: 
100 μg/mL) and HepG2 (IC50: 165 μg/mL) [37] as 
compared to cisplatin and tamoxifen, the human 
anticancer drugs. Froemming [39] reported the 
methanolic extract of T. crispa displayed a dose-
dependent cytotoxic effect on MDA-MB-231 and 
MCF-7 cancer cell lines with an IC50 value of 44.8 
and 33.8 μg/mL, respectively.  
 
Atherosclerosis inhibitory activity 
 
The study conducted by Amom et al [41] 
revealed T. crispa stem aqueous extract delays 
the development of atherosclerosis by 
suppressing the total cholesterol, triglycerides, 
low density lipoprotein levels but showed a 





Oral administration of ethanolic extract of T. 
crispa twice daily for 8 weeks at a dose of 100 
mg/kg and 200 mg/kg was found to possess a 
significant effect on the thioacetamide-induced 
liver cirrhosis in rats [42]. 
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The cardio-protective studies on the n-butanol 
extract of T. crispa demonstrated the presence of 
at least three different cardiovascular-active 
components which acted through (1) β2-
adrenergic receptors to cause a decrease in 
blood pressure, and β1- and β2-adrenergic 
receptors to cause an increase in heart rate, (2) 
α-adrenergic receptors to cause an increase in 
blood pressure and heart rate, and (3) a non-
adrenergic and noncholinergic pathway to cause 
a decrease in MAP and heart rate [43]. 
 
Central analgesic activity 
 
The dried extract of stem of T. crispa exhibited 
promising central analgesic activity at a dosage 
of 666 mL [44]. 
 
Cytochrome inhibitory activities 
 
Usia et al [45] studied the inhibitory effects of 30 
indonesian medicinal plants against cytochrome 
P450 3A4 (CYP3A4) and CYP2D6 with a 
radiometric assay and suggested that T. crispa, 
showed inhibitory activity over 70% on the 
metabolism mediated by CYP3A4. Subehan et al 
[46] showed that among 30 other plants in an 
inhibitory assay of cytochrome P450 3A4 
(CYP3A4) and CYP2D6 via erythromycin N-
demethylation and dextromethorphan O-
demethylation activities in human liver 
microsomes that T. crispa, exhibited more than 




Oral administration of T. crispa extract was found 
to display potent in vitro insulinotropic activity in 
the human and rat islets and HIT-T15 B cells 
[47]. Sriyapai et al [48] examined the T. crispa 
dry powder for hypoglycemic effect on the 
patients with metabolic syndrome. Administrated 
of 250 mg T. crispa dry powder twice a day for 2 
months was proven to decrease fasting blood 
glucose significantly from the baseline. The study 
by Noipha and Ninla-aesong [49] indicated that 
the extract of T. crispa enhances the glucose 
uptake by in L6 myotubes which was associated 
to the increased levels of GLUT1 transporter, 




A large number of secondary metabolites and 
biological activities have been reported from T. 
crispa; however, it would be valuable to conduct 
bioassay-guided phytochemical studies on this 
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